Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masao Toki is active.

Publication


Featured researches published by Masao Toki.


Alimentary Pharmacology & Therapeutics | 2005

A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection‐induced ulceration

Yasuharu Yamaguchi; Naoya Katsumi; Masaru Tauchi; Masao Toki; Kenji Nakamura; Kei Aoki; Yasushi Morita; Miki Miura; Katsuro Morozumi; Hitoshi Ishida; Shin'ichi Takahashi

Background : It has been reported that inhibitors of gastric acid secretion prevent bleeding after endoscopic mucosal resection for mucosal gastric neoplasm. However, uncertain whether an histamine2‐receptor antagonist or proton‐pump inhibitor is more effective.


Journal of Clinical Gastroenterology | 2007

Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm.

Yasuharu Yamaguchi; Naoya Katusmi; Kei Aoki; Masao Toki; Kenji Nakamura; Nobutsugu Abe; Katsuro Morozumi; Masanori Sugiyama; Hitoshi Ishida; Shin'ichi Takahashi

Background Endoscopic mucosal resection (EMR) is effective treatment for mucosal gastric neoplasm. Endoscopic submucosal dissection (ESD), a novel EMR method, has been reported to enable en bloc resection more frequently than conventional EMR methods such as strip biopsy (SB). However, ESD requires more time than SB. A small lesion can be resected en bloc and effectively treated with SB. Goal To evaluate using a 15 mm resection area as the dividing line between SB and ESD prospectively. Study SB was applied for resection area less than 15 mm (SB group) and ESD for 15 mm or larger resection (ESD group). We compared characteristics of lesions and outcomes of EMR between the 2 groups. Results Ninety lesions were prospectively assigned to SB group (36 lesions) and ESD group (54 lesions). The average neoplasm size was 9.0±3.9 mm in the SB group and 19.1±11.3 mm in the ESD group (P<0.01). The average resection time was 11.7±5.8 minutes in the SB group and 128.9±102.8 minutes in the ESD group (P<0.01). The complete resection rate was 91.6% in the SB group and 83.3% in the ESD group (P=0.25). The complication rate was not significantly different between SB group and ESD group (11.1% vs. 16.7%, P=0.12). During follow-up (median 23±5 mo), 1 patient in each group, who had piecemeal resection at original EMR had recurrent neoplasm. Conclusions Gastric mucosal neoplasms which require only small (<15 mm) resection can be treated with SB, as effectively as with ESD.


Gastrointestinal Endoscopy | 2012

Gastric mucosal longitudinal tears after drowning

Tomohiko Hasue; Yasuharu Yamaguchi; Kenji Nakamura; Masao Toki; Masanori Sugiyama; Shin'ichi Takahashi

A 90-year-old man with spondylosis deformans but no other pertinent medical history was found drowning in a public bath. He was successfully resuscitated by mouthto-mouth respiration without cardiac massage; regurgitation of gastric contents was noted during resuscitation. Three hours after admission to the hospital he had tarry stools and a decrease in hematocrit from 31.1% to 21.5%. EGD revealed several longitudinal mucosal tears with visible vessels in the upper body of the stomach and a massive blood clot in the stomach (A; arrowhead indicates visible vessel). Hemostasis was achieved by endoscopic clipping (B; arrow indicates clip). He had no further bleeding and was discharged in stable condition. DISCLOSURE All authors disclosed no financial relationships relevant to this publication.


Gastroenterology | 2013

Mo1411 Diabetes Mellitus As a Risk Factor for Pancreatic Cancer-for Realization of Efficient Screening of Pancreatic Cancer in Patients With Diabetes Mellitus

Masao Toki; Yasuharu Yamaguchi; Isamu Kurata; Kouichi Tabei; Hideyuki Hata; Tomohiko Hasue; Kenji Nakamura; Shin'ichi Takahashi


Gastrointestinal Endoscopy | 2008

Predictive Risk Factors for Rebleeding and Thirty-Day Mortality After Endoscopic Hemostasis in Elderly Bleeding Peptic Ulcer Patients

Masao Toki; Yasuharu Yamaguchi; Kenji Nakamura; Kei Aoki; Shin'ichi Takahashi


Nihon Naika Gakkai Zasshi | 2013

A Rare Case of Drug Induced Liver Damage by Suspected Additive of Thyradin

Masao Toki; Eiji Itagaki; Isamu Kurata; Yasuhito Uchida; Kouichi Tabei; Hideyuki Hata; Tomohiko Hasue; Yasuharu Yamaguchi; Hitoshi Ishida; Shin'ichi Takahashi


Gastrointestinal Endoscopy | 2013

Tu1387 The Usefulness and Safety of Carbon Dioxide Insufflation During Endoscopic Retrograde Cholangiopancreatography in Elderly Patients: a Prospective, Double-Blind, Randomized, Controlled Trial

Kenji Nakamura; Yasuharu Yamaguchi; Masaru Tauchi; Masao Toki; Shin'ichi Takahashi


Pediatric Dermatology | 2017

A case of acute cholecystitis with cholecystolithiasis and gallbladder cancer diagnosed and treated by endoscopic nasal gallbladder drainage

Takeshi Nosaka; Isamu Kurata; Tomoyuki Goto; Tsubasa Yoshida; Yuri Fukasawa; Hirotaka Ohta; Kazushige Ochiai; Koichi Gondo; Yoshihiko Ohmori; Shunsuke Watanabe; Tetsuya Nakazato; Masao Toki; Shin Takahashi; Masanori Sugiyama; Hideaki Mori; Tadakazu Hisamatsu


Anticancer Research | 2017

A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer

Shiho Arima; Kyoko Shimizu; Tomoyoshi Okamoto; Masao Toki; Yutaka Suzuki; Naohiro Okano; Daisuke Naruge; Kirio Kawai; Takaaki Kobayashi; Akiyoshi Kasuga; Hiroshi Kitamura; Atuko Takasu; Fumio Nagashima; Masanori Sugiyama; Junji Furuse


Pediatric Dermatology | 2016

Two patients successfully treated using the rendezvous method via the percutaneous transhepatic gall bladder drainage route

Isamu Kurata; Masao Toki; Hirotaka Ohta; Kazushige Ochiai; Koichi Gondo; Kensuke Arai; Shunsuke Watanabe; Yoko Jinbo; Akiko Ohno; Hideyuki Hata; Kenji Nakamura; Yasuharu Yamaguchi; Katsuro Morozumi; Hideaki Mori; Tadakazu Hisamatsu; Shin Takahashi

Collaboration


Dive into the Masao Toki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge